4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-23-000160
Chief Executive Officer gave up 7,141 shares (to pay taxes)
- Chief Executive Officer acquired 20,635 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2022-12-31 | Option exercise | +13,912 | 77,147.8 | D: show line 1 in the form | ||
| Robinson Chandler Chief Executive Officer | 2022-12-31 | Shares withheld for taxes | −4,814 | $2.37 | $11,409 | 72,333.8 | D: show line 2 in the form |
| Robinson Chandler Chief Executive Officer | 2023-01-01 | Option exercise | +6,723 | 79,056.8 | D: show line 3 in the form | ||
| Robinson Chandler Chief Executive Officer | 2023-01-01 | Shares withheld for taxes | −2,327 | $2.37 | $5,515 | 76,729.8 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2022-12-31 | Option exercise · Restricted Stock Units | −13,912 | 151,171 | D: show line 5 in the form | |||||
| Robinson Chandler Chief Executive Officer | 2023-01-01 | Option exercise · Restricted Stock Units | −6,723 | 6,724 | D: show line 6 in the form |
Loading xslF345X03/rdgdoc.xml…